• PGF2α/PTGFR Drives Endometrial Breakdown

  2026-10-04

  A 2024 mouse menstrual-like model study identifies PGF2α/PTGFR signaling as an important regulator of endometrial disintegration and vascular permeability after progesterone withdrawal. The work further connects HIF-1α-dependent transcriptional control of Ptgfr with angiogenic balance, while pharmacological inhibition provides evidence for a causal contribution to tissue breakdown.

• Fluoxetine HCl in Serotonin and Motivation Research

  2026-10-03

  A source-grounded overview of Fluoxetine HCl research, focusing on serotonergic signaling, developmental SSRI exposure, reward-related behavior, and the evidence linking nucleus accumbens mu opioid receptors to motivation deficits in mice. The discussion distinguishes supplier information from dissertation findings and outlines translational limits without providing experimental procedures.

• Perphenazine Research Workflows for D2 Signaling

  2026-10-02

  Perphenazine links dopamine D2 receptor pharmacology with mitochondrial, behavioral, and host-directed infection models. This practical guide shows how to build concentration-controlled assays, interpret its polypharmacology, and troubleshoot workflows spanning neuropharmacology research, opioid tolerance suppression, and macrophage antibacterial activity.

• XAV-939: Reliable Wnt Pathway Assay Design

  2026-10-01

  A practical, scenario-based guide to using XAV-939 (SKU A1877) in viability, proliferation, differentiation, and cytotoxicity workflows. It connects tankyrase inhibition with solvent control, assay interpretation, protocol optimization, and evidence-based product selection.

• DAPT (GSI-IX) for Notch Assays

  2026-10-01

  DAPT (GSI-IX) provides a practical way to separate γ-secretase-dependent Notch effects from amyloid precursor protein processing in cell, co-culture, and disease models. Its value is especially clear in FOXN1-driven thymic epithelial programming, where timed Notch inhibition can help reveal lineage and maturation mechanisms.

• Collagen VI Scaffolds Mature iPSC Islet Organoids

  2026-09-30

  Zhu and colleagues show that decellularized amniotic membrane extracellular matrix can improve the viability, architecture, and endocrine function of iPSC-derived islet organoids. Their findings identify collagen VI as a key niche component and distinguish hydrogel-based maturation support from sheet-based engraftment support, providing a useful framework for biomimetic islet engineering.

• Demethyleneberberine in Neurodegenerative Disorders

  2026-09-30

  The 2022 Molecular Biology Reports review proposes Demethyleneberberine (DMB), a berberine metabolite, as a neuroprotective candidate acting through neuroinflammation, oxidative stress, mitochondrial dysfunction, and energy-regulatory pathways. Its main contribution is a testable mechanistic framework centered on NF-κB, MAPK, and AMPK signaling, while emphasizing that most supporting evidence remains preclinical or indirect.

• 4-Methoxychalcone-1 for Reliable Cell Assays

  2026-09-29

  This scenario-driven guide explains how biomedical researchers can evaluate 4-Methoxychalcone-1 (SKU C8661) in cell viability, proliferation, and cytotoxicity workflows without overstating undocumented product performance. It connects practical assay controls with evidence on cellular heterogeneity and secretion phenotypes to support reproducible interpretation.

• DAPT (GSI-IX) in Corneal Cell-Fate Assays

  2026-09-29

  DAPT (GSI-IX) is more than a γ-secretase inhibitor in corneal epithelial research: its value depends on how it is separated from a six-component signaling environment. This article translates a landmark mouse corneal culture study into practical assay-design, controls, and interpretation guidance.

• 6-OHDA Hydrochloride in Parkinson’s Models

  2026-09-28

  6-OHDA hydrochloride is a powerful chemical tool for studying catecholaminergic neurodegeneration. This article explains its oxidative lesion mechanism and shows how protein-corona research can sharpen assay design, controls, and interpretation without overstating cross-domain evidence.

• DAPT (GSI-IX) in Ischemic Angiogenesis Research

  2026-09-28

  Explore how DAPT (GSI-IX) helps test the contribution of Notch signaling to endothelial responses and ischemic tissue remodeling. A critical reading of a thymosin-β4 study shows how to connect pathway inhibition with functional assays—and where the evidence stops.

• Placebo-Controlled Mianserin Trial: Findings and Limits

  2026-09-27

  A 14-day double-blind inpatient trial reported greater improvement in depressive symptoms and sleep with mianserin hydrochloride than with placebo, providing direct placebo-controlled evidence beyond comparisons with established antidepressants. Its short duration, small female-only sample, and concurrent nitrazepam use make the findings informative but not definitive for current clinical practice or receptor-level explanations.

• Fingolimod and the Geography of T-Cell Therapy

  2026-09-26

  Fingolimod (FTY720) reshapes where lymphocytes can travel, while emerging magnetic strategies seek to guide T cells into tumors. This article examines the biological tension between these approaches and how to design experiments that distinguish immune-cell location from immune-cell activation.

• H2S, Persulfidation, and Ferroptosis in NSCLC

  2026-09-25

  A 2024 Molecular Cell study identifies hydrogen sulfide (H2S)-mediated persulfidation of S-adenosyl homocysteine hydrolase as a metabolic route to ferroptosis sensitization in non-small cell lung cancer (NSCLC). The findings connect reduced homocysteine, cysteine, and glutathione availability—especially under low-cystine conditions—to increased ferroptotic vulnerability, suggesting a strategy to investigate alongside cystine-depletion treatments.

• Pol II Degradation Triggers Transcription-Independent Death

  2026-09-25

  The preprint argues that RNA polymerase II degradation can activate cell death through a mechanism distinct from simply shutting down transcription. Its findings shift attention toward the fate of hypophosphorylated Pol IIA and a mitochondria-linked apoptotic response, while leaving important questions about mechanism and generalizability for further study.

8569 records 2/572 page Previous Next 12345 下5页 Last page